(Q37030772)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18076214%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

review article

1 reference

title

Proton pump inhibitors: do differences in pharmacokinetics translate into differences in clinical outcomes? (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18076214%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

1 reference

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18076214%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

author name string

Kwong Ming Fock

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18076214%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

Lean Choo Bee

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18076214%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

Edmund Jon Deon Lee

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18076214%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

publication date

1 January 2008

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18076214%20AND%20SRC:MED&resulttype=core&format=json

Clinical Pharmacokinetics

29 December 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18076214%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

volume

47

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18076214%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18076214%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

page(s)

1-6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18076214%20AND%20SRC:MED&resulttype=core&format=json

Rabeprazole vs esomeprazole in non-erosive gastro-esophageal reflux disease: a randomized, double-blind study in urban Asia.

29 December 2019

cites work

1 reference

Crossref

https://api.crossref.org/works/10.2165%2F00003088-200847010-00001

Review article: the opportunities and benefits of extended acid suppression

21 January 2018

1 reference

12 December 2020

The treatment of gastric ulcer with antisecretory drugs. Relationship of pharmacological effect to healing rates

1 reference

12 December 2020

A comparison of five maintenance therapies for reflux esophagitis

1 reference

12 December 2020

CYP2C19 genotype and the PPIs--focus on rabeprazole

1 reference

12 December 2020

The effect of CYP2C19 polymorphisms on H. pylori eradication rate in dual and triple first-line PPI therapies: a meta-analysis

1 reference

12 December 2020

Effect of CYP2C19 and MDR1 polymorphisms on cure rate in patients with acid-related disorders with Helicobacter pylori infection

1 reference

12 December 2020

A comparison of omeprazole with ranitidine for ulcers associated with nonsteroidal antiinflammatory drugs. Acid Suppression Trial: Ranitidine versus Omeprazole for NSAID-associated Ulcer Treatment (ASTRONAUT) Study Group

1 reference

12 December 2020

A prospective randomized comparative trial showing that omeprazole prevents rebleeding in patients with bleeding peptic ulcer after successful endoscopic therapy

1 reference

12 December 2020

Acid inhibition on the first day of dosing: comparison of four proton pump inhibitors

1 reference

12 December 2020

Determinants of non-response in Helicobacter pylori eradication trials

1 reference

12 December 2020

CYP2C19 polymorphism is a major predictor of treatment failure in white patients by use of lansoprazole-based quadruple therapy for eradication of Helicobacter pylori

1 reference

12 December 2020

Gastric acid control with esomeprazole, lansoprazole, omeprazole, pantoprazole, and rabeprazole: a five-way crossover study

1 reference

12 December 2020

Is there an optimal degree of acid suppression for healing of duodenal ulcers? A model of the relationship between ulcer healing and acid suppression

1 reference

12 December 2020

Helicobacter pylori eradication, CYP2C19 and omeprazole doses

1 reference

12 December 2020

Review article: the clinical pharmacology of proton pump inhibitors

1 reference

12 December 2020

Appropriate acid suppression for the management of gastro-oesophageal reflux disease

1 reference

12 December 2020

Review article: cytochrome P450 and the metabolism of proton pump inhibitors--emphasis on rabeprazole

1 reference

12 December 2020

Pharmacokinetic studies with esomeprazole, the (S)-isomer of omeprazole

1 reference

12 December 2020

Esomeprazole provides improved acid control vs. omeprazole In patients with symptoms of gastro-oesophageal reflux disease

1 reference

12 December 2020

Effect of CYP2C19*17 gene variant on Helicobacter pylori eradication in peptic ulcer patients

1 reference

12 December 2020

Comparison of five antisecretory agents acting via gastric H+/K+-ATPase

1 reference

12 December 2020

The effects of lansoprazole on erosive reflux oesophagitis are influenced by CYP2C19 polymorphism

1 reference

12 December 2020

Pharmacogenomics-based tailored versus standard therapeutic regimen for eradication of H. pylori

1 reference

12 December 2020

Comparison of the effects of immediate-release omeprazole powder for oral suspension and pantoprazole delayed-release tablets on nocturnal acid breakthrough in patients with symptomatic gastro-oesophageal reflux disease

1 reference

12 December 2020

Efficacy of triple therapy with rabeprazole for Helicobacter pylori infection and CYP2C19 genetic polymorphism

1 reference

12 December 2020

Influence of CYP2C19 polymorphism and Helicobacter pylori genotype determined from gastric tissue samples on response to triple therapy for H pylori infection

1 reference

12 December 2020

Esomeprazole 40 mg twice daily in triple therapy and the efficacy of Helicobacter pylori eradication related to CYP2C19 metabolism

1 reference

12 December 2020

Speed of healing and symptom relief in grade II to IV gastroesophageal reflux disease: a meta-analysis

1 reference

12 December 2020

Effect of concomitant dosing of famotidine with lansoprazole on gastric acid secretion in relation to CYP2C19 genotype status

1 reference

12 December 2020

Proton pump inhibitor treatment for acute peptic ulcer bleeding

1 reference

12 December 2020

Stereoselective metabolism of omeprazole by human cytochrome P450 enzymes

1 reference

12 December 2020

Effect of genetic differences in omeprazole metabolism on cure rates for Helicobacter pylori infection and peptic ulcer

1 reference

12 December 2020

Review article: immediate-release proton-pump inhibitor therapy--potential advantages

1 reference

12 December 2020

The efficacy of Helicobacter pylori eradication related to CYP2C19 metabolism

1 reference

12 December 2020

Effect on intragastric pH of a PPI with a prolonged plasma half-life: comparison between tenatoprazole and esomeprazole on the duration of acid suppression in healthy male volunteers

1 reference

12 December 2020

Influence of smoking and CYP2C19 genotypes on H. pylori eradication success

1 reference

12 December 2020

Tenatoprazole, a novel proton pump inhibitor with a prolonged plasma half-life: effects on intragastric pH and comparison with esomeprazole in healthy volunteers

1 reference

12 December 2020

The choice of proton pump inhibitor: does it matter?

1 reference

12 December 2020